Work

Correlation of stable disease (SD) as best response with survival outcomes in patients (pts) with clear cell (cc) metastatic renal cell carcinoma (mRCC) treated with high-dose interleukin-2 (HD IL-2).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.4577

Authors: Joseph Merriman, Kinjal Parikh, Srinivas Kiran Tantravahi, Alli M. Straubhar, Archana M. Agarwal, Arun Sendilnathan, Joan Van Atta, Julia A. Batten, Kenneth F. Grossmann, Wolfram E. Samlowski, David D. Stenehjem, Neeraj Agarwal

Institutions: University of Utah, Huntsman Cancer Institute, ARUP Laboratories (United States), Comprehensive Cancer Centers of Nevada

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603373141

Cites:

Cited by: 1

Related to: 10